Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001650664-24-000126

CEO sold 1,618 shares at $2.08 ($3,361)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

O'Neill Gilmore Neil · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-03 Sale : show line 1 in the form 10b5-1 −1,618 $2.08 $3,361 312,106 D
Open-market sales · 1,618 sh · avg $2.08 · $3,361
Loading xslF345X05/wk-form4_1733434825.xml…